MW 410.5 Da. Cell-permeable activator of adenylyl cyclase. Interacts directly with the catalytic subunit of the enzyme to increase intracellular cAMP levels. Positive inotropic, platelet antiaggregatory and antihypertensive actions in vivo. 3D Growth matrix component used in liver organoid generation.
3',5'-cyclic AMP synthetase, AC1, AC2, ADCY1_HUMAN, ADH water channel, AQP-CD, AQP2_HUMAN, ATP pyrophosphate lyase 2, ATP pyrophosphate-lyase, ATP pyrophosphate-lyase 1, ATP pyrophosphate-lyase 8, Adenylate cyclase 1, Adenylate cyclase 1, fetal brain, type I, Adenylate cyclase 2, Adenylate cyclase 2 (brain), Adenylate cyclase 8, Adenylate cyclase II, Adenylate cyclase type 1, Adenylate cyclase type 2, Adenylate cyclase type I, Adenylate cyclase type II, Adenylate cyclase type VIII, Adenylyl cyclase 1, Adenylyl cyclase 8 brain, Aquaporin 2 collecting duct, Aquaporin-2, Aquaporin-CD, Aquaporine 2, BG 37, BXR, Brain adenylate cyclase 1, Brain adenylate cyclase 8, CSE, Ca(2+)/calmodulin-activated adenylyl cyclase, Choreoathetosis/spasticity episodic (paroxysmal choreoathetosis/spasticity), Collecting duct water channel protein, DFNB44, DKFZP586J0917, DYT17, DYT18, DYT9, EC 4.6.1.1, EIG12, Erythrocyte/hepatoma glucose transporter, FLJ16822, FLJ45092, FLJ99588, G protein coupled bile acid receptor BG 37, G-protein coupled bile acid receptor 1, G-protein coupled receptor GPCR19, GLUT, GLUT-1, GLUT1DS, GLUTB, GPBAR 1, GPBAR_HUMAN, GPCR, GPCR 19, GPR 131, GT1, GTG1, GTR1_HUMAN, Glucose transporter 1, Glucose transporter type 1, Glucose transporter type 1, erythrocyte/brain, Gm1018, Gtg3, HBAC1, HBAC2, HD 7, HD 7a, HDAC 7A, HDAC7_HUMAN, HTLVR, HepG2 glucose transporter, Histone deacetylase 7, Histone deacetylase 7A, Human T cell leukemia virus (I and II) receptor, KIAA1060, LGR 7, LGR7.1, LGR7.10, LGR7.2, Leucine-rich repeat-containing G-protein coupled receptor 7, M-BAR, MGC133314, MGC138347, MGC141895, MGC141896, MGC142177, MGC34501, MGC40597, Membrane bile acid receptor, Membrane-type receptor for bile acids, NR1I2_HUMAN, Nuclear receptor subfamily 1 group I member 2, ONR 1, OTTHUMP00000202813, OTTHUMP00000202814, OTTHUMP00000215173, OTTHUMP00000215174, OTTHUMP00000215175, Orphan nuclear receptor PAR 1, Orphan nuclear receptor PXR, PAR, PAR q, PED, PRR, Pregnane X receptor, RATGTG1, RXFP1_HUMAN, Receptor for HTLV 1 and HTLV 2, Relaxin family peptide receptor 1, Relaxin receptor 1, Relaxin/insulin like family peptide receptor 1, SXR, Solute carrier family 2, Solute carrier family 2 (facilitated glucose transporter), member 1, Solute carrier family 2, facilitated glucose transporter member 1, Steroid and xenobiotic receptor, TGR 5, Type II adenylate cyclase, WCH-CD, Water channel aquaporin 2, Water channel protein for renal collecting duct, adenyl cyclase, adenylate cyclase 1 (brain), deafness, autosomal recessive 44, erythrocyte/brain, facilitated glucose transporter member 1, hBG 37, hGPCR 19, pregnane X nuclear receptor variant 2
MW 410.5 Da. Cell-permeable activator of adenylyl cyclase. Interacts directly with the catalytic subunit of the enzyme to increase intracellular cAMP levels. Positive inotropic, platelet antiaggregatory and antihypertensive actions in vivo. 3D Growth matrix component used in liver organoid generation.
Cell-permeable activator of adenylyl cyclase. Interacts directly with the catalytic subunit of the enzyme to increase intracellular cAMP levels. Positive inotropic, platelet antiaggregatory and antihypertensive actions in vivo. 3D Growth matrix component used in liver organoid generation.
Adenylate cyclase 1 (AC1) also known as adenylate cyclase is an enzyme that catalyzes the conversion of ATP to cyclic AMP (cAMP) in response to various signaling molecules. This enzyme has a molecular mass of approximately 130 kDa. AC1 is localized mainly in neurons of the central nervous system. It acts as an adenylate cyclase activator responding to signals and modulating the downstream effects via cAMP production. Forskolin is a well-known pharmacological activator of adenylate cyclases including AC1 which can elevate intracellular cAMP levels.
Adenylate cyclases like AC1 play critical roles in signal transduction by regulating the intracellular concentration of cAMP a second messenger involved in numerous cellular processes. AC1 is part of a complex including G-protein coupled receptors which regulate its activity. The presence of AC1 in the brain suggests its involvement in neural signaling and neuroplasticity contributing to the modulation of synaptic transmission and the function of neuronal networks.
Adenylate cyclase activity is integral in the cAMP signaling pathway where it mediates the effects of neurotransmitters and hormones. This pathway is important for processes such as learning and memory where cAMP acts as an important mediator. AC1 activity is linked to proteins involved in the Calcium/Calmodulin-dependent protein kinase pathway providing a bridge between calcium signaling and cAMP production which influences synaptic plasticity and neurocognitive functions.
AC1 has connections to conditions like depression and addiction where dysregulation of cAMP signaling is observed. Altered activity of AC1 can affect other proteins such as protein kinase A which plays a role in emotional and reward responses. Understanding the function of AC1 in these conditions aids in exploring potential therapeutic targets for neuropsychiatric and neurodegenerative diseases.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
2D chemical structure image of ab120058, Forskolin, Adenylyl cyclase activator
A: A 10 minute application of the AC activator Forskolin (FSK, 50 μM) potentiates the Cortico-LA EPSC in young WT animals.
B: The same protocol is inefficient in adult WT mice (B1) and Mecp2308/Y mice (B2).
C: Summary plot of similar pharmacological experiments in WT and KO mice.
***: P<0.001.
Number of recorded cells is indicated.
Anti-XIAP antibody ab2541 staining XIAP in MCF7 cells treated with forskolin (ab120058), by ICC/IF. Increase in XIAP expression correlates with increased concentration of forskolin, as described in literature.
The cells were incubated at 37°C for 2h in media containing different concentrations of ab120058 (forskolin) in DMSO, fixed with 100% methanol for 5 minutes at -20°C and blocked with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% tween for 2h at room temperature. Staining of the treated cells with Anti-XIAP antibody ab2541 (1 µg/ml) was performed overnight at 4°C in PBS containing 1% BSA and 0.1% tween. A DyLight 488 goat anti-rabbit polyclonal antibody (Goat Anti-Rabbit IgG H&L (DyLight® 488) preadsorbed ab96899) at 1/250 dilution was used as the secondary antibody.
1e7 3T3-L1 cells were treated for 15 minutes with 1 µM dexamethasone (Dexamethasone, anti-inflammatory glucocorticoid ab120743) and 1 µg x mL-1 insulin (Recombinant human Insulin protein (Active) ab123768) with the addition of 50 µM forskolin (ab120058), 0.5 mM IBMX (IBMX, Non-specific cAMP and cGMP inhibitor ab120840) or 0.1 mM 8-CPT-cAMP (8-(4-Chlorophenylthio)adenosine 3',5'-cyclic monophosphate (8-CPT-cAMP), Cell permeable cAMP analog. ab120424), extracted according to the protocol. Lysates were diluted 50-fold, and tested in duplicates (+/-SD).
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com